Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
The Motherisk Nausea and Vomiting of Pregnancy (NVP) Forum
Motherisk receives questions from around the world about morning sickness symptoms, effects, treatments and ways to cope. Those questions and answers are posted here for anyone to read, provided the reader acknowledges and accepts the proviso and disclaimer below.
NVP Counsellor
Date: 2007-08-07
Question:
Why is Dicletin not available in the States? It was previously marketed under the name bendictin but Merrill Dow pulled it after a class action law suit which did not support the charges. If it is safe why did they stop selling it? Have there been any studies in Canada about the side effects of birth deformities? If so I would be interested in seeing them.
Answer:
As you correctly noted, Bendectin was never
found to increase the risk for malformations,however
because of the cost of the lawsuits to the company,
they decided to stop manufacturing it. The drug has
been marketed in Canada for many years under the name
Diclectin by a company called Duchesnay. It contains
pyridoxine 10mg and doxylamine 10mg in a delayed
release form and is the only drug that is recommended
for use in pregnancy because of its safety












![Validate my RSS feed [Valid RSS]](/images/rssValid.png)